Carregant...
Cost-Effectiveness and Public Health Impact of Influenza Vaccine Strategies for US Seniors
OBJECTIVES: Four influenza vaccines are available in the US for persons aged ≥65 years: trivalent inactivated influenza vaccine (IIV3), quadrivalent inactivated influenza vaccine (IIV4), a more expensive high-dose IIV3, and a newly approved adjuvanted IIV3, but their cost-effectiveness when all 4 va...
Guardat en:
| Publicat a: | J Am Geriatr Soc |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5302117/ https://ncbi.nlm.nih.gov/pubmed/27709600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jgs.14323 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|